Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. (Q52716139)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 March 2018

edit

Language	Label	Description	Also known as
English	Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.	scientific article published on 21 March 2018

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

title

Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

author name string

Rhian M Touyz

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

Sandra M S Herrmann

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

Joerg Herrmann

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

publication date

21 March 2018

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

published in

Journal of the American Society of Hypertension

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

cites work

Tumor angiogenesis: therapeutic implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of exercise on coronary endothelial function in patients with coronary artery disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endothelium: dysfunction and beyond

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-edged role of statins in angiogenesis signaling

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autocrine VEGF signaling is required for vascular homeostasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home blood-pressure monitoring in patients receiving sunitinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-blockers and coronary flow reserve: the importance of a vasodilatory action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemostatic complications of angiogenesis inhibitors in cancer patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF-A splicing: the key to anti-angiogenic therapeutics?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hypertension in angiogenesis inhibitor-treated patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo evidence of duality effects for lovastatin in a nude mouse cancer model.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombotic events in patients with cancer receiving antiangiogenesis agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversibility of capillary density after discontinuation of bevacizumab treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib-induced acute myocardial infarction due to coronary artery spasm

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exercise training restores the endothelial response to vascular growth factors in patients with stable coronary artery disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of coronary artery spasm

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: pleiotropic and dose-dependent effect on tumor vascular stabilization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic therapies for glioblastoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approach to chemotherapy-associated thrombosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Healing After Myocardial Infarction: A Loosely Defined Process.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of thromboembolic events in cancer patients receiving bevacizumab according to the Japanese Adverse Drug Event Report database

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New treatment options for metastatic renal cell carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis Inhibitors in NSCLC.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of renal cell carcinoma: Current status and future directions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clini

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/29703600

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.JASH.2018.03.008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

PMC publication ID

6168784

0 references

PubMed publication ID

29703600

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29703600

retrieved

6 May 2018

reference URL

http://europepmc.org/abstract/MED/29703600

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52716139&oldid=1478524081"